Related Experiment Videos
[Postmarketing surveillance on Benazepril]
Jun Lu1, Li-ming Li, Wei-hua Cao
1Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing 100083, China.
Summary
Benazepril demonstrated long-term safety and effectiveness in managing hypertension over three years. Most patients maintained optimal compliance, achieving significant blood pressure reductions with minimal serious adverse events.
Area of Science:
- Cardiovascular medicine
- Pharmacology
- Public health
Context:
- Essential hypertension affects a significant portion of the adult population.
- Long-term medication adherence and efficacy are crucial for chronic disease management.
- Postmarketing surveillance provides real-world data on drug performance and safety.
Purpose:
- To evaluate the long-term (3-year) efficacy, safety, and tolerability of benazepril in essential hypertensive patients.
- To assess medication adherence and blood pressure control in a community-based setting.
- To identify any adverse drug reactions associated with benazepril use.
Summary:
- A 3-year community-based surveillance study involved 1831 essential hypertensive patients in Shanghai.
- 74.3% of patients showed optimal compliance. After 3 years, significant percentages achieved target systolic (75.7%) and diastolic (87.4%) blood pressure levels.
- Benazepril use resulted in notable reductions in SBP, DBP, and pulse pressure. Cough was the most frequent adverse drug reaction, occurring more in women.
Impact:
- Benazepril is confirmed as a safe and well-tolerated antihypertensive medication for long-term use.
- The study highlights the importance of sustained medication adherence for effective hypertension management.
- Real-world data supports benazepril's role in achieving and maintaining blood pressure control in general hypertensive populations.